Tumor necrosis factor α decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2834-2839

  Franchimont, Denis ^a,b   Martens, Henri ^a   Hagelstein, Marie Therese ^a   Louis, Edouard ^a   Dewe, Walthere ^a   Chrousos, George P ^b   Belaiche, Jacques ^a   Geenen, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; HORMONE INHIBITION; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0033309752     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.8.5931     Document Type: Article

References (36)

1. Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates
2. Molecular mechanisms of glucocorticoid resistance and hypersensitivity
3. Molecular determinants of glucocorticoid receptor, function and tissue sensitivity to glucocorticoids
4. Syndromes of glucocorticoid resistance
5. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
6. IFNγ mediates increased glucocorticoid receptor expression in murine macrophages
7. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids
8. A novel action of interleukin-13: Induction of diminished monocyte glucocorticoid receptor binding affinity
9. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids
10. MIF as a glucocorticoid-induced modulator of cytokine production
11. The expanding universe of T-cell subsets: Th1, Th2 and more
12. IL-10 acts on the antigen presenting cells to inhibit cytokine production by Th-1 cells
13. IL-10 inhibits cytokine production by activated macrophages
14. Interleukin 10
15. The pathophysiology of tumor necrosis factors
16. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
17. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes
18. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures
19. Differential regulation of interleukin-10 and IL-12 by glucocorticoids in vitro
20. Direct stimulation of cytokines in whole blood. Comparison with isolated PBMCs stimulation
21. Dexamethasone suppresses gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes
22. Methylprednisolone differentially regulates IL-10 and tumor necrosis factor production durIng routIne endotoxemia
23. Hypercortisolemia increases plasma interleukin 10 concentrations durIng human endotoxemia. A clinical research center study
24. Up-regulation of monocytic IL-10 by tumor necrosis α and cAMP elevating drugs
25. Isolation of the human Interleukin-10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines
26. Regulation of tumor necrosis factor alpha transcription in macrophages: Involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B
27. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids
28. Interleukin 1 receptor antagonist: A new member of the interleukin 1 family
29. Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin
30. Dexamethasone potently enhances phorbol ester-induced IL-1 beta gene expression and nuclear factor NF-kappaB activation
31. Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells
32. Immuno-suppression by glucocorticoids: Inhibition of NF-kappaB activity through induction of I kappa B synthesis
33. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions
34. Interleukin 10 inhibits nuclear factor κB activation in human monocytes
35. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
36. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology